IUD Insertion Pain
8
1
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
12.5%
1 terminated out of 8 trials
80.0%
-6.5% vs benchmark
50%
4 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Intrauterine Device Insertion Pain Management
Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology
Development of a Pain Control Options Menu for IUD Insertion
Oral Ketorolac for IUD Pain Reduction
the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion
Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion
Dinoprostone vs Misoprostol Before LNG-IUD Insertion
Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.